JoelWNealMDPhD

Oncology • Palo Alto, CA

Assistant Professor, Medicine - Oncology, Stanford University Medical Center

Join to view full profile

Dr. Neal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Neal's full profile

Already have an account?

Office
300 Pasteur Dr
# MC5500
Palo Alto, CA 94305
Phone+1 650-723-4000

Fax+1 650-498-5840
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2010
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
Northwestern University The Feinberg School of MedicineClass of 2004

Certifications & Licensure

CA State Medical License 2010 - 2025
MA State Medical License 2006 - 2011
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations Start of enrollment: 2009 Oct 01
Active, not recruiting
Phase 2
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies Start of enrollment: 2011 Jun 01
Completed
Phase 2
Molecular Analysis of Thoracic Malignancies Start of enrollment: 2011 Aug 01
Enrolling by invitation
Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Start of enrollment: 2011 Oct 01
Completed
Phase 2
Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors Start of enrollment: 2012 Oct 01
Terminated
Phase 2
Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2016 Oct 01
Active, not recruiting
Phase 2
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) Start of enrollment: 2021 Apr 08
Recruiting
Phase 2
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations Start of enrollment: 2020 Jan 10
Active, not recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Che...
Joel Neal, Nick Pavlakis, Sang-We Kim, Yasushi Goto, Sun Min Lim, Giannis Mountzios, Elena Fountzilas, Anastasia Mochalova, Daniel C Christoph, Alessandra Bearz, Xavie...> ;Journal of Clinical Oncology. 2024 Mar 29
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial.
Loo, B. W., Caressa Hui, Eleanor Brown, Samantha Wong, Millie Das, Heather Wakelee, Joel Neal, Kavitha Ramchandran, Nathaniel J Myall, Daniel Pham, Lei Xing, Yong Yang...> ;Clinical Lung Cancer. 2024 Mar 1
1 citations
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine EC...
Walter, A., Lee, J., Streck, J., Gareen, I., Herman, B., Kircher, S., Carlos, R., Kumar, S., Mayer, I., Saba, N., Fenske, T., Neal, J., Atkins, M., Hodi, F., Kyriakopo...> ;Cancer. 2024 Feb 1
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort St...
D'Aiello, A., Owen, D. H., Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, Jamie Feng, Frances Shepherd, Chao Xu, David Kaldas, Jhanelle E Gray, Thomas J Dilling, Joel...> ;Journal of Thoracic Oncology. 2024 Jan 24
Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry.
Trope, W., Trope, W., Loukia G Karacosta, Danny Pancirer, Jordan S Preiss, Jalen A Benson, Winston Trope, Joseph B Shrager, Arthur Wai Sung, Joel W Neal, Sean C Bendal...> ;Scientific Reports. 2023 Dec 8
Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemo...
Prawitz, T., Lin, H., Hong, J., Tan, M., Proskorovsky, I., Hernandez, L., Jin, S., Zhang, P., Lin, J., Nguyen, D., Ou, S., Patel, J., Neal, J.> ;Clinical Lung Cancer. 2023 Dec 4
Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung Cancer.
Caressa Hui, Cesar Marquez, Brianna Lau, Millie Das, Nathaniel J Myall, Mohana Roy, Heather A Wakelee, Joel W Neal, Nataliya Kovalchuk, Alex Chin, Maximilian Diehn, Mi...> ;Clinical Lung Cancer. 2024 Mar 1
5 citations
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.
Eunji Choi, Victoria Y Ding, Sophia J Luo, Kevin Ten Haaf, Julie T Wu, Jacqueline V Aredo, Lynne R Wilkens, Neal D Freedman, Leah M Backhus, Ann N Leung, Rafael Meza, ...> ;JAMA Oncology. 2023 Dec 1
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
Eunji Choi, Sophia J Luo, Victoria Y Ding, Julie T Wu, Ashok V Kumar, Jason Wampfler, Martin C Tammemägi, Lynne R Wilkens, Jacqueline V Aredo, Leah M Backhus, Joel W N...> ;Cancer. 2024 Mar 1
5 citations
Real-World Response and Outcomes in Patients With NSCLC WithExon 20 Insertion Mutations.
Sai-Hong Ignatius Ou, Huamao M Lin, Jin-Liern Hong, Yu Yin, Shu Jin, Jianchang Lin, Minal Mehta, Danny Nguyen, Joel W Neal> ;JTO Clinical and Research Reports. 2023 Oct 1
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer.
Chloe C Su, Julie T Wu, Eunji Choi, Nathaniel J Myall, Joel W Neal, Allison W Kurian, Henning Stehr, Douglas Wood, Solomon M Henry, Leah M Backhus, Ann N Leung, Heathe...> ;JAMA Network Open. 2023 Sep 5
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).
Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst, David R Gandara, Joel W Neal, Ticiana A Leal, Jyoti D Patel, Konstantin H Dragnev, Saiama N ...> ;JCO Precision Oncology. 2023 Sep 1
2 citations
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.
Jürgen Wolf, Pierre-Jean Souquet, Koichi Goto, Alexis Cortot, Christina Baik, Rebecca Heist, Tae Min Kim, Ji-Youn Han, Joel W Neal, Aaron S Mansfield, Isabelle Gillote...> ;Clinical Lung Cancer. 2023 Nov 1
Adjuvant osimertinib for resected EGFR-mutated non-small cell lung cancer: a game-changer?
Shruti R Patel, Joel W Neal> ;Translational Lung Cancer Research. 2023 Jul 31
6 citations
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
Christine M Bestvina, Marina C Garassino, Joel W Neal, Heather A Wakelee, Maximilian Diehn, Everett E Vokes> ;Journal of Clinical Oncology. 2023 Sep 1
5 citations
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.
Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, Paul Stockhammer, Iris K van Alderwerelt van Rosenburgh, Anna Wurtz, Andrew J Piper-Valillo, Zofia Piotrows...> ;Clinical Cancer Research. 2023 Jun 1
12 citations
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, Natalie I Vokes, Pingjun Chen, Morteza Salehjahromi, Kang Qin, Sheeba J Sujit, Xuetao Lu, Elliana Young, Qasem Al-Tas...> ;The Lancet. Digital Health. 2023 Jul 1
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Har...
J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, Benjamin P Levy, Hossein Borghaei, Bruna Pellini, Michael R Costello, Jonathan E Dowell, Gene Finley, Chao H Huang,...> ;Clinical Lung Cancer. 2023 Nov 1
Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Antiangiogenic Agents.
Brianna C Lau, Yufan F Wu, Hyunsoo J No, Ryan B Ko, Max D Devine, Millie S Das, Joel W Neal, Heather A Wakelee, Kavitha Ramchandran, Michael F Gensheimer, Maximilian D...> ;Journal of Thoracic Oncology. 2023 Jul 1
Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparison.
Sai-Hong I Ou, Huamao M Lin, Jin-Liern Hong, Yu Yin, Shu Jin, Jianchang Lin, Minal Mehta, Pingkuan Zhang, Danny Nguyen, Joel W Neal> ;Lung Cancer. 2023 May 1
Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors.
Thomas Yang Sun, Brandon Nguyen, Simon B Chen, Yasodha Natkunam, Sukhmani Padda, Matt van de Rijn, Robert West, Joel W Neal, Heather Wakelee, Jonathan W Riess> ;JTO Clinical and Research Reports. 2023 Apr 1
6 citations
Osimertinib in NSCLC With Atypical-Activating Mutations: A Retrospective Multicenter Study.
Jingran Ji, Jacqueline V Aredo, Andrew Piper-Vallillo, Laura Huppert, Julia K Rotow, Hatim Husain, Susan Stewart, Rosemary Cobb, Heather A Wakelee, Collin M Blakely, M...> ;JTO Clinical and Research Reports. 2023 Mar 1
4 citations
Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer.
Michael F Gensheimer, Divya Gupta, Manali I Patel, Touran Fardeen, Rachel Hildebrand, Winifred Teuteberg, Briththa Seevaratnam, Mary Khay Asuncion, Nina Alves, Brian R...> ;JCO Oncology Practice. 2023 Feb 1
5 citations
Pharmacovigilance Analysis of Heart Failure Associated With Anti-HER2 Monotherapies and Combination Regimens for Cancer.
Sarah Waliany, Jennifer Caswell-Jin, Fauzia Riaz, Nathaniel Myall, Han Zhu, Ronald M Witteles, Joel W Neal> ;JACC. Cardiooncology. 2023 Feb 1
1 citations
Immunotherapy-Associated Atherosclerosis: A Comprehensive Review of Recent Findings and Implications for Future Research.
Antonia Chan, Stefan Torelli, Evaline Cheng, Ryan Batchelder, Sarah Waliany, Joel Neal, Ronald Witteles, Patricia Nguyen, Paul Cheng, Han Zhu> ;Current Treatment Options in Cardiovascular Medicine. 2023 Jan 1
Join now to see all

Lectures

Osimertinib with chemotherapy for EGFR-mutant NSCLC at progression: Safety profile and survival analysis.
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Other

Personalized, genotype-directed therapy for advanced non-small cell lung cancer
Neal JW, Sequist LV
http://www.uptodate.com/contents/personalized-genotype-directed-therapy-for-advanced-non-small-cell-
UpToDate, Wolters Kluwer Health - 2013-02-25

Press Mentions

Exelixis Announces Results from COSMIC-021 Trial of Cabozantinib in Combination with Atezolizumab in Multiple Advanced Solid Tumor TypesMay 13th, 2020
Sequencing Switches, Intriguing Combos Being Debated in ALK+ NSCLCAugust 8th, 2017
Presents State of the Science Summit™: Updates in Management of Adenocarcinoma of the LungJune 12th, 2017
Join now to see all